Sally C. Pipes
Commentary
After COVID-19 subsides, ‘the telehealth revolution must march on’
It’s hard to find a silver lining in a pandemic. But one of the few may be the rapid rise of telemedicine. With people stuck at home, doctors retooled their practices to see patients via videoconference. Insurance companies and regulators expanded the number of services available via telemedicine—and made reimbursement ...
Sally C. Pipes
July 28, 2020
Business & Economics
It’s time to bring our economy back to life. Paying workers to stay home won’t help
The federal government’s emergency unemployment benefits are set to expire this week. Set at $600 a week by the CARES Act — the economic rescue package Congress passed back in March — the emergency benefits were intended to supplement state unemployment insurance and offset the economic carnage caused by the coronavirus lockdowns. That extra ...
Sally C. Pipes
July 25, 2020
Commentary
Trump’s drug pricing executive orders harmful to patients — will hinder development of new drugs
President Trump issued four executive orders Friday that he said will lower drug prices — but in reality, three of the orders will cause far more harm than good and represent electioneering at its worst. The three harmful executive orders allow the importation of drugs from Canada, reduce the price ...
Sally C. Pipes
July 24, 2020
Drug Pricing
Sally Pipes and Lars Larson Examine Trump Ex. Orders on Drug Pricing
Sally C. Pipes joins the Lars Larson Show to question the Trump administration’s latest action on drug pricing. President Trump plans to sign an executive order on Friday, July 24 that puts limits on drug pricing in the United States. Pipes explains that 90 percent of drugs are generic and ...
Sally C. Pipes
July 24, 2020
Commentary
Why Trump administration should say goodbye to ‘Buy America’
It’s not often that Joe Biden agrees with President Trump. But the former vice president found common ground with his presumptive opponent this month when he announced he would outline a plan to bring medical manufacturing back to the United States, something the president has long endorsed. This isn’t the ...
Sally C. Pipes
July 23, 2020
Commentary
Executive Order On Drug Price Controls Would Backfire
Rumor has it that President Trump will soon issue a sweeping executive order to lower prescription drug prices by fiat. Nothing is set in stone. But the order would reportedly index the government’s reimbursements for medicines to the prices that Britain, France, Canada, and other developed nations pay. Since all those nations ...
Sally C. Pipes
July 22, 2020
Commentary
Biden a moderate? Sanders, AOC plans for candidate suggest this instead
Presumptive Democratic presidential nominee Joe Biden has long been considered a political moderate. A new report from his “unity” task forces should put that reputation to rest. The 110-page document offers detailed policy recommendations for an incoming Biden administration. It would represent the most left-wing governing program of any president ...
Sally C. Pipes
July 20, 2020
Commentary
Medicaid Expansion Will Add To Oklahoma’s Woes
Late last month, Oklahoma voters narrowly approved a ballot measure expanding the state’s Medicaid program to childless adults making up to 138% of the poverty level under the terms of Obamacare. Missouri could follow suit next month when a similar ballot initiative comes up for a vote. Medicaid expansion seems ...
Sally C. Pipes
July 20, 2020
Commentary
Sally C. Pipes Talks COVID-19, State Closures on the Larry Elder Show
Possibility of huge tax increases, discrepancies with COVID-19 numbers and the overall impact of 80 percent of, 45 percent of people who have died were in nursing homes, and only 3 percent is 25 to 44-years-old. Elder and Pipes also talk about the transmission rates among children, the announcement that ...
Sally C. Pipes
July 14, 2020
Coronavirus
Sally Pipes Talks COVID-19 Remdisivir Treatment on Alabama Morning News
Sally C. Pipes joined JT Nysewamder on Alabama Morning News in Birmingham to talk about the latest developments with the drug remdisivir. The drug, produced by Gilead, is being studied for potential use against COVID-19. Pipes and JT also discuss the cost of the drug, and how expensive it is ...
Sally C. Pipes
July 14, 2020
After COVID-19 subsides, ‘the telehealth revolution must march on’
It’s hard to find a silver lining in a pandemic. But one of the few may be the rapid rise of telemedicine. With people stuck at home, doctors retooled their practices to see patients via videoconference. Insurance companies and regulators expanded the number of services available via telemedicine—and made reimbursement ...
It’s time to bring our economy back to life. Paying workers to stay home won’t help
The federal government’s emergency unemployment benefits are set to expire this week. Set at $600 a week by the CARES Act — the economic rescue package Congress passed back in March — the emergency benefits were intended to supplement state unemployment insurance and offset the economic carnage caused by the coronavirus lockdowns. That extra ...
Trump’s drug pricing executive orders harmful to patients — will hinder development of new drugs
President Trump issued four executive orders Friday that he said will lower drug prices — but in reality, three of the orders will cause far more harm than good and represent electioneering at its worst. The three harmful executive orders allow the importation of drugs from Canada, reduce the price ...
Sally Pipes and Lars Larson Examine Trump Ex. Orders on Drug Pricing
Sally C. Pipes joins the Lars Larson Show to question the Trump administration’s latest action on drug pricing. President Trump plans to sign an executive order on Friday, July 24 that puts limits on drug pricing in the United States. Pipes explains that 90 percent of drugs are generic and ...
Why Trump administration should say goodbye to ‘Buy America’
It’s not often that Joe Biden agrees with President Trump. But the former vice president found common ground with his presumptive opponent this month when he announced he would outline a plan to bring medical manufacturing back to the United States, something the president has long endorsed. This isn’t the ...
Executive Order On Drug Price Controls Would Backfire
Rumor has it that President Trump will soon issue a sweeping executive order to lower prescription drug prices by fiat. Nothing is set in stone. But the order would reportedly index the government’s reimbursements for medicines to the prices that Britain, France, Canada, and other developed nations pay. Since all those nations ...
Biden a moderate? Sanders, AOC plans for candidate suggest this instead
Presumptive Democratic presidential nominee Joe Biden has long been considered a political moderate. A new report from his “unity” task forces should put that reputation to rest. The 110-page document offers detailed policy recommendations for an incoming Biden administration. It would represent the most left-wing governing program of any president ...
Medicaid Expansion Will Add To Oklahoma’s Woes
Late last month, Oklahoma voters narrowly approved a ballot measure expanding the state’s Medicaid program to childless adults making up to 138% of the poverty level under the terms of Obamacare. Missouri could follow suit next month when a similar ballot initiative comes up for a vote. Medicaid expansion seems ...
Sally C. Pipes Talks COVID-19, State Closures on the Larry Elder Show
Possibility of huge tax increases, discrepancies with COVID-19 numbers and the overall impact of 80 percent of, 45 percent of people who have died were in nursing homes, and only 3 percent is 25 to 44-years-old. Elder and Pipes also talk about the transmission rates among children, the announcement that ...
Sally Pipes Talks COVID-19 Remdisivir Treatment on Alabama Morning News
Sally C. Pipes joined JT Nysewamder on Alabama Morning News in Birmingham to talk about the latest developments with the drug remdisivir. The drug, produced by Gilead, is being studied for potential use against COVID-19. Pipes and JT also discuss the cost of the drug, and how expensive it is ...